New insights for preventing transfusion-transmitted cytomegalovirus and other white blood cell-associated viral infections

Transfusion

Volumn 53, Issue 10, 2013, Pages 2112-2116

  Roback, John D ^a   Josephson, Cassandra D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENETIC SIMILARITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; KAPOSI SARCOMA; LEUKOCYTE; REVIEW; SEROCONVERSION; TORQUE TENO VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; CYTOMEGALOVIRUS INFECTIONS; DELTARETROVIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LEUKOCYTES;

EID: 84885776118     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12366     Document Type: Review

References (13)

1. Hakre S, Manak MM, Murray CK, Davis KW, Bose M, Harding AJ, Maas PR, Jagodzinski LL, Kim JH, Michael NL, Rentas FJ, Peel SA, Scott PT, Tovanabutra S,. Transfusion-transmitted human T-lymphotropic virus Type 1 infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010. Transfusion 2013; 53: 2174-2180.
2. Hewitt PE, Davison K, Howell DR, Taylor GP,. Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction. Transfusion 2013; 53: 2166-2173.
3. Dollard SC, Roback JD, Gunthel C, Amin MM, Barclay S, Patrick E, Kuehnert MJ,. Measurements of human herpesvirus 8 viral load in blood before and after leukoreduction filtration. Transfusion 2013; 53: 2162-2165.
4. Vamvakas EC,. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005; 19: 181-199. (Pubitemid 40943570)
5. Ziemann M, Juhl D, Görg S, Hennig H,. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients. Transfusion 2013; 53: 2181-2187.
6. Zhang C, Buchanan H, Andrews W, Evans A, Pass RF,. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding. J Clin Virol 2006; 35: 338-342. (Pubitemid 43188985)
7. Furui F, Satake M, Hoshi Y, Uchida S, Suzuki K, Tadokoro K,. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors. Transfusion 2013; 53: 2188-2195.
8. Ziemann M, Unmack A, Steppat D, Juhl D, Gorg S, Hennig H,. The natural course of primary cytomegalovirus infection in blood donors. Vox Sang 2010; 99: 24-33.
9. Ziemann M, Heuft HG, Frank K, Kraas S, Gorg S, Hennig H,. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections. Transfusion 2013; 53: 1088-1094.
10. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd D, Woxenius S, Busch MP,. Multicenter evaluation of PCR methodologies to detect cytomegalovirus (CMV) DNA in blood donors. Transfusion 2001; 41: 1249-1257. (Pubitemid 33000961)
11. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF,. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180: 702-707. (Pubitemid 29411355)
12. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G,. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998; 177: 1170-1175. (Pubitemid 28194253)
13. Josephson CD, Castillejo MI, Caliendo A, Waller EK, Zimring J, Easley KA, Kutner M, Hillyer CD, Roback JD,. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfus Med Rev 2011; 25: 125-132.